Literature DB >> 8348060

Ornithine decarboxylase and polyamines in colorectal neoplasia and mucosa.

L J Hixson1, H S Garewal, D L McGee, D Sloan, M B Fennerty, R E Sampliner, E W Gerner.   

Abstract

Ornithine decarboxylase (ODC) and polyamines are intimately involved in normal cellular proliferation and are likely to play a role in carcinogenesis. ODC activity and polyamine content were measured in tissue samples obtained during colonoscopy from 48 benign neoplastic polyps (20 tubular adenomas; 28 villous adenomas), 18 cancers (including 5 malignant polyps), and adjacent mucosa. ODC activity in polyp and cancer tissue specimens was higher than in adjacent mucosa in 75 and 83% of pairs, respectively. Similarly, putrescine, spermidine, and spermine contents were higher in the majority of polyps and cancers compared to adjacent mucosa. ODC activity and polyamine content in colonic mucosa from 10 patients without a history of colorectal neoplasia were not different from adjacent mucosal values in the patients with neoplasia. In conclusion, ODC and polyamines are elevated in the majority of colorectal neoplasms, but amounts in normal mucosa do not differentiate between patients with cancer, benign neoplastic polyps, and normal subjects.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8348060

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  14 in total

Review 1.  DFMO: targeted risk reduction therapy for colorectal neoplasia.

Authors:  Christina M Laukaitis; Eugene W Gerner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-08       Impact factor: 3.043

2.  Dietary polyamine intake and risk of colorectal adenomatous polyps.

Authors:  Ashley J Vargas; Betsy C Wertheim; Eugene W Gerner; Cynthia A Thomson; Cheryl L Rock; Patricia A Thompson
Journal:  Am J Clin Nutr       Date:  2012-05-30       Impact factor: 7.045

3.  Cloning and expression of ornithine decarboxylase gene from human colorectal carcinoma.

Authors:  Hai-Yan Hu; Xian-Xi Liu; Chun-Ying Jiang; Yan Zhang; Ji-Feng Bian; Yi Lu; Zhao Geng; Shi-Lian Liu; Chuan-Hua Liu; Xiao-Ming Wang; Wei Wang
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

4.  Dietary polyamine intake and colorectal cancer risk in postmenopausal women.

Authors:  Ashley J Vargas; Erin L Ashbeck; Betsy C Wertheim; Robert B Wallace; Marian L Neuhouser; Cynthia A Thomson; Patricia A Thompson
Journal:  Am J Clin Nutr       Date:  2015-07-01       Impact factor: 7.045

Review 5.  Targeting polyamines and inflammation for cancer prevention.

Authors:  Naveen Babbar; Eugene W Gerner
Journal:  Recent Results Cancer Res       Date:  2011

Review 6.  Polyamines as mediators of APC-dependent intestinal carcinogenesis and cancer chemoprevention.

Authors:  Nathaniel S Rial; Frank L Meyskens; Eugene W Gerner
Journal:  Essays Biochem       Date:  2009-11-04       Impact factor: 8.000

7.  Prostanoids, ornithine decarboxylase, and polyamines in primary chemoprevention of familial adenomatous polyposis.

Authors:  Francis M Giardiello; Robert A Casero; Stanley R Hamilton; Linda M Hylind; Jill D Trimbath; Deborah E Geiman; Katharine R Judge; Walter Hubbard; G Johan A Offerhaus; Vincent W Yang
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

Review 8.  Current concepts in colorectal cancer prevention.

Authors:  Patricia A Thompson; Eugene W Gerner
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2009-08       Impact factor: 3.869

9.  Cystathionine-beta-synthase inhibition for colon cancer: Enhancement of the efficacy of aminooxyacetic acid via the prodrug approach.

Authors:  Celia Chao; John R Zatarain; Ye Ding; Ciro Coletta; Amy A Mrazek; Nadiya Druzhyna; Paul Johnson; Haiying Chen; Judy L Hellmich; Antonia Asimakopoulou; Kazunori Yanagi; Gabor Olah; Petra Szoleczky; Gabor Törö; Fredrick J Bohanon; Minal Cheema; Rachel Lewis; David Eckelbarger; Akbar Ahmad; Katalin Módis; Ashley Untereiner; Bartosz Szczesny; Andreas Papapetropoulos; Jia Zhou; Mark R Hellmich; Csaba Szabo
Journal:  Mol Med       Date:  2016-05-16       Impact factor: 6.354

10.  The effect of difluoromethylornithine on decreasing prostate size and polyamines in men: results of a year-long phase IIb randomized placebo-controlled chemoprevention trial.

Authors:  Anne R Simoneau; Eugene W Gerner; Ray Nagle; Argyrios Ziogas; Sharon Fujikawa-Brooks; Hagit Yerushalmi; Thomas E Ahlering; Ronald Lieberman; Christine E McLaren; Hoda Anton-Culver; Frank L Meyskens
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-02       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.